CLSD - Clearside Biomedical, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2023)Next Qtr. (Sep 2023)Current Year (2023)Next Year (2024)
No. of Analysts5555
Avg. Estimate-0.14-0.15-0.58-0.6
Low Estimate-0.15-0.16-0.6-0.66
High Estimate-0.12-0.13-0.54-0.53
Year Ago EPS-0.13-0.13-0.55-0.58
Revenue EstimateCurrent Qtr. (Jun 2023)Next Qtr. (Sep 2023)Current Year (2023)Next Year (2024)
No. of Analysts4443
Avg. Estimate150k160k500k6.39M
Low EstimateN/AN/AN/A600k
High Estimate350k350k1.05M9.61M
Year Ago Sales384k6.52M1.33M500k
Sales Growth (year/est)-60.90%-97.50%-62.30%1,178.00%
Earnings History2022-06-292022-09-292022-12-302023-03-30
EPS Est.-0.13-0.03-0.13-0.14
EPS Actual-0.13-0.13-0.16-0.15
Difference0-0.1-0.03-0.01
Surprise %0.00%-333.30%-23.10%-7.10%
EPS TrendCurrent Qtr. (Jun 2023)Next Qtr. (Sep 2023)Current Year (2023)Next Year (2024)
Current Estimate-0.14-0.15-0.58-0.6
7 Days Ago-0.14-0.15-0.58-0.6
30 Days Ago-0.14-0.15-0.58-0.62
60 Days Ago-0.14-0.15-0.58-0.64
90 Days Ago-0.15-0.16-0.61-0.68
EPS RevisionsCurrent Qtr. (Jun 2023)Next Qtr. (Sep 2023)Current Year (2023)Next Year (2024)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days2114
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesCLSDIndustrySector(s)S&P 500
Current Qtr.-7.70%N/AN/AN/A
Next Qtr.-15.40%N/AN/AN/A
Current Year-5.50%N/AN/AN/A
Next Year-3.40%N/AN/AN/A
Next 5 Years (per annum)N/AN/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A